Time course of the effect of intravenous dimetindene maleate. 1990

D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
Zyma GmbH, Hauptabteilung Medizin und Entwicklung, München, FRG.

In order to evaluate the time course of its effects, dimetindene maleate has been investigated in a histamine provocation model in man. Eight healthy male volunteers were treated i.v. with 4 mg dimetindene maleate or sodium chloride solution in a double blind, cross over study. Intracutaneous histamine injections were given at -1, 2, 5, 14, 17, 20, 23, 26, and 29 h following drug administration and the areas of flares and wheals were measured after 5, 10, 20, and 30 min. There was strong inhibition of the development both of flares and wheals, which was more pronounced for the former. Baseline adjusted areas under the curve differed significantly following drug and placebo treatment. The maximum effect was observed at 2 h. The mean residence time of the inhibitory effect was calculated to be approximately 13 h compared to the mean residence time of dimetindene in blood of approximately 5 h, which indicates a non-linear relationship between blood level and effect.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D004115 Dimethindene A histamine H1 antagonist. It is used in hypersensitivity reactions, in rhinitis, for pruritus, and in some common cold remedies. Dimethpyrindene,Dimethindene Maleate,Dimetindene,Fenistil,Forhistal,Maleate, Dimethindene
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin

Related Publications

D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
January 1984, Biopharmaceutics & drug disposition,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
January 1986, La Clinica terapeutica,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
January 1978, Dermatologica,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
January 1985, Arzneimittel-Forschung,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
February 2019, The Journal of surgical research,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
November 1992, Arzneimittel-Forschung,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
December 1990, Arzneimittel-Forschung,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
January 2004, Journal of separation science,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
December 2000, Arzneimittel-Forschung,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
January 2013, Acta poloniae pharmaceutica,
Copied contents to your clipboard!